These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 477605)

  • 1. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flumezapine, an antagonist of central dopamine and serotonin receptors.
    Fuller RW; Mason NR
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):23-34. PubMed ID: 2879325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin.
    Fletcher PJ
    Psychopharmacology (Berl); 1988; 96(2):237-42. PubMed ID: 3148151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
    Fuller RW; Kurz KD; Mason NR; Cohen ML
    Eur J Pharmacol; 1986 Jun; 125(1):71-7. PubMed ID: 3732393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists.
    Fuller RW; Snoddy HD
    Endocrinology; 1981 Oct; 109(4):1026-32. PubMed ID: 6116593
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that serotonin receptors are involved in the anticonvulsant effect of yohimbine in mice.
    Ludvig N; György L; Vizi ES
    Psychopharmacology (Berl); 1986; 88(1):82-5. PubMed ID: 2868485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
    Broekkamp CL; Garrigou D; LLoyd KG
    Pharmacol Biochem Behav; 1980 Nov; 13(5):643-6. PubMed ID: 6969405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptor antagonists block a natural, short term surge in serum growth hormone levels.
    Arnold MA; Fernstrom JD
    Endocrinology; 1978 Oct; 103(4):1159-63. PubMed ID: 744138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central serotonin antagonist activity of ketanserin.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):151-4. PubMed ID: 6505385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.